About
Here you'll find all the latest updates to the CMF site, as well as breaking news from the world of cardiometabolic diseases!
Latest Updates
All ▼
Tirzepatide Once Weekly for the Treatment of Obesity
FDA approves subcutaneous tirzepatide injection (Mounjaro™) for Type 2 Diabetes
New Ozempic Dose Approved by FDA
Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes
Kadowaki T et al.
Hao Z et al.
